Active substanceHexetidineHexetidine Similar drugsTo uncover Hexoral® aerosol locally Johnson & Johnson, LLC Russia Hexoral® solution locally Johnson & Johnson, LLC Russia Hexetidine spray locally YUZHFARM, LLC Russia Maxcold® Lor spray locally Otisipharm, PAO Stomatidin® solution locally Boznalek, AO Bosnia and Herzegovina Stopangin® spray locally Teva Pharmaceutical Enterprises Co., Ltd. Israel Stopangin® solution locally Teva Pharmaceutical Enterprises Co., Ltd. Israel Dosage form: & nbspspray for topical application Composition:Composition per 1 bottleActive substance:hexiethidine-0.0577 g;Excipients:Methyl salicylate 0.0067 g, aniseic essential oil 0.0140 g, eucalyptus essential oil 0.0004 g, essential oil of orange flowers 0.0033 g, sassafras essential oil 0.0033 g, peppermint essential oil 0.0231 g, levomenthol 0 , 0067 g, sodium saccharinate monohydrate 0.0083 g, glycerol 85% 7.6598 g, ethanol 96% 19.3877 g Description:Transparent colorless or almost colorless liquid with a specific odor. Pharmacotherapeutic group:Antiseptic ATX: & nbspA.01.A.B.12 Hexetidine Pharmacodynamics:Antiseptic for topical use. It also has antifungal activity and analgesic properties when applied to the mucous membrane. Stopangin® has an enveloping effect.The effect lasts 10-12 hours. Indications:Infectious and inflammatory diseases of the oral cavity and pharynx (tonsillitis, including Vincent's angina, pharyngitis, stomatitis, aphthous ulcers of the mouth, glossitis, periodontitis, gum bleeding). Fungal diseases (thrush) of the oral cavity and larynx before and after surgery on the oral cavity and larynx. Injuries of the oral cavity and larynx. Prevention of infection of the alveoli after extraction of the tooth.Hygiene of the oral cavity to eliminate bad breath from the mouth (deodorant). Prevention of superinfection with collapsing tumors of the oral cavity and larynx. Contraindications:The drug should not be used with hypersensitivity to the components of the drug, with atrophic pharyngitis, children under the age of 8, and during pregnancy (I trimester). Dosing and Administration:Locally.Instructions for patients on the use of applicators:The dispensed distribution of the drug from the vial is carried out using a mechanical sprayer and an applicator (see Figure A1 or A2)1. If the applicator is placed in a plastic bag, remove it from the bag using scissors or a similar tool (see Figure B2)2.Check the integrity of the applicator. If the applicator is damaged, its use is prohibited.3. Remove the protective cover from the mechanical sprayer.4. Place the applicator on the vial (see figure B3).5. Press 2-3 times to allow the solution to pass through the nebulizer, and then spray the drug.6. Place the tube of the applicator 2 to 3 cm into the mouth, hold the breath and press the applicator 2 times, with the first press, spray the drug on the right side, and on the second - in the left. When spraying, hold the bottle in an upright position.Before use, rinse applicators with hot water and always check their integrity. Do not use a damaged applicator.The procedure should be carried out 2 times a day, unless the doctor has appointed otherwise. The drug should be used after meals or in between meals for 5-7 days. Side effects:There may be a temporary burning sensation of the oral mucosa after using the drug, which spontaneously quickly disappears. In exceptional cases, people with hypersensitivity may experience an allergic reaction.In case of unusual reactions, consult a doctor about the advisability of further use of the drug. Overdose:Cases of an overdose have not been revealed. Interaction:Not known. Special instructions:The drug should not be inhaled! In this regard, it can be prescribed only to children older than 8 years and only when they do not resist an extraneous object (applicator in the mouth), and if they are able to hold their breath when injecting the drug. In case of an overdose or accidental ingestion of the drug inside the child, it is necessary to consult a doctor. Avoid contact with the eyes. The expediency of simultaneous application of Stopangin® with other medicines is determined by the doctor. When appointing a doctor other medications, tell him about the use of Stopangin®. In case of worsening of health, temperature increase, ineffectiveness of medical procedures or unusual reactions, you should consult a doctor. Without consultation with a doctor, the drug can be used no longer than 5-7 days. The preparation contains 62% ethanol. Attention drivers: the drug should be taken no later than 30 minutes before the start of driving. Effect on the ability to drive transp. cf. and fur:The drug should be taken no later than 30 minutes before the start of driving. Form release / dosage:Spray for topical application 0,2%. Packaging:For 30 ml in vials of PE (polyethylene) or PET (polyethylene terephthalate), equipped with a mechanical sprayer and a lid, which protects the nebulizer.Each bottle, complete with an applicator, is placed in a cardboard box with instructions for use.Applicator can be both in a polyethylene bag, and without it. Storage conditions:At a temperature of 10 ° C to 25 ° C, in a place protected from light. Do not freeze.Keep out of the reach of children. Shelf life:2 years.Do not use after the expiration date printed on the package. Terms of leave from pharmacies:Without recipe Registration number:П N014966 / 02 Date of registration:27.03.2009 The owner of the registration certificate:Teva Pharmaceutical Enterprises Co., Ltd.Teva Pharmaceutical Enterprises Co., Ltd. Israel Manufacturer: & nbspTEVA Czech Industries, s.r.o. Czech Republic Representation: & nbspTeva Teva Israel Information update date: & nbsp2015-12-08 Illustrated instructions × Illustrated instructions Instructions